Inspire Medical Systems, Inc. To Present At Jefferies London Healthcare Conference
Date
11/6/2024 8:01:27 AM
(MENAFN- GlobeNewsWire - Nasdaq) MINNEAPOLIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare conference on Wednesday, November 20, 2024.
Inspire is scheduled to present at 11:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here .
Webcast replays of the presentations will be available for two weeks following the presentations in the Event Archive section of Inspire's Investor website at .
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology of its kind that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit .
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
...
617-549-2443
MENAFN06112024004107003653ID1108856880
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.